AI-generated summary
The authors report a prospective, blinded, descriptive study of 21 patients with community-acquired pneumonia, 11 of whom received near-infrared LED therapy (940 nm) alongside conventional treatment and 10 of whom received conventional treatment alone. They found that several blood measures returned to normal values faster in the LED group, which they interpret as greater treatment efficiency.
- Participants
- 21
- Who or what was studied
- Patients with community-acquired pneumonia undergoing treatment, divided into an LED group (11 patients) and a control group (10 patients)
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The study is small with only 21 patients divided into two unequal groups, and the abstract does not state whether the control group was a matched comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
- Power
- 6 W
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Photobiomodulation, Near-infrared, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.